Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced

Erika C Claud1, Lei Lu, Pauline M Anton

  • 1Pediatric Gastroenterology Unit, Massachusetts General Hospital, 114 16th Street, Charlestown, MA 02129, USA. eclaud@partners.org

Insights

Necrotizing enterocolitis may stem from immature intestines overreacting to bacterial infections. Lower IkappaB gene expression in immature cells amplifies this damaging IL-8 response, contributing to infant inflammatory bowel disease.

Area of Science:

  • Gastroenterology
  • Immunology
  • Neonatology

Background:

  • Necrotizing enterocolitis (NEC) is a severe intestinal inflammatory disease primarily affecting premature infants.
  • The exact cause of NEC is unknown, but an exaggerated immune response in the immature gut to microbial stimuli is suspected.
  • Interleukin-8 (IL-8) is a key cytokine involved in inflammatory responses.

Purpose of the Study:

  • To investigate the role of developmental regulation of the intestinal immune response in NEC pathogenesis.
  • To compare the IL-8 response to bacterial infection in immature versus mature enterocytes.
  • To explore the involvement of IkappaB genes in this differential response.

Main Methods:

  • Compared IL-8 production in immature and mature human enterocyte cell lines after bacterial infection.
  • Assessed flagellin-dependency of the IL-8 response.
  • Measured IkappaB gene expression in both cell types.
  • Validated findings in primary rat enterocytes.
  • Utilized transfection to alter IkappaBalpha levels in immature cells.

Main Results:

  • Immature enterocytes exhibited a significantly higher IL-8 response to bacterial infection compared to mature enterocytes.
  • This heightened response was flagellin-dependent in both cell types.
  • Immature enterocytes expressed lower levels of specific IkappaB genes than mature enterocytes.
  • Increasing IkappaBalpha expression in immature cells attenuated the IL-8 response.

Conclusions:

  • Demonstrated a novel developmental regulation of IkappaB expression in the intestine.
  • This regulation impacts the IL-8 response to bacterial infection.
  • Altered IkappaB expression may contribute to the pathogenesis of age-specific inflammatory bowel diseases like NEC in newborns.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...